EUVIMEDEUVIMED entdecken
Open Access

Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies

Kanak Raina, Chris D Forbes, Rebecca Stronk, Jonathan P Rappi, Kyle J Eastman, Nilesh Zaware, Xinheng Yu, Hao Li, Amit Bhardwaj, Samuel W Gerritz, Mia Forgione, Abigail Hundt und 23 weitere

Cell Chemical Biology · 2024-08 · 31 (8) · 1490-1502.e42

DOI: 10.1016/j.chembiol.2024.07.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Chemical Biology, 2024-08. Verfasst von Kanak Raina und 34 weiteren Autor:innen. Beteiligte Einrichtung: Halda Therapeutics OpCo Inc, New Haven, CT, USA. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Small Molecule Libraries, Antineoplastic Agents. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We describe a protein proximity inducing therapeutic modality called Regulated Induced Proximity Targeting Chimeras or RIPTACs: heterobifunctional small molecules that elicit a stable ternary complex between a target protein (TP) selectively expressed in tumor cells and a pan-expressed protein essential for cell survival. The resulting co-operative protein-protein interaction (PPI) abrogates the function of the essential protein, thus leading to death selectively in cells expressing the TP. This approach leverages differentially expressed intracellular proteins as novel cancer targets, with the advantage of not requiring the target to be a disease driver. In this chemical biology study, we design RIPTACs that incorporate a ligand against a model TP connected via a linker to effector ligands such as JQ1 (BRD4) or BI2536 (PLK1) or CDK inhibitors such as TMX3013 or dinaciclib. RIPTACs accumulate selectively in cells expressing the HaloTag-FKBP target, form co-operative intracellular ternary complexes, and induce an anti-proliferative response in target-expressing cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Cycle ProteinsSmall Molecule LibrariesAntineoplastic AgentsHumansNeoplasmsCell ProliferationTriazolesPolo-Like Kinase 1Protein Serine-Threonine KinasesAzepinesProto-Oncogene ProteinsTranscription FactorsIndolizinesCell Line, TumorBridged Bicyclo Compounds, HeterocyclicLigandsProtein Kinase InhibitorsHeterocyclic Compounds, 2-RingNuclear ProteinsBromodomain Containing ProteinsCyclic N-OxidesPyridinium Compounds

Stichwörter der Autor:innen

Halda TherapeuticsRIPTACanticancer drugsbiotechnologychemical biologydrug discoveryheterobifunctional moleculesoncologyprotein proximityternary complex

Substanzen

Cell Cycle ProteinsSmall Molecule LibrariesAntineoplastic AgentsTriazolesPolo-Like Kinase 1Protein Serine-Threonine KinasesAzepinesProto-Oncogene ProteinsTranscription Factorsdinaciclib

Autor:innen und Institutionen

  • Halda Therapeutics OpCo Inc, New Haven, CT, USA.
  • Department of Molecular, Cellular, & Developmental Biology, Yale University, New Haven, CT, USA.
  • Halda Therapeutics OpCo Inc, New Haven, CT, USA. Electronic address: kat.kayser-bricker@haldathera.com.
  • Department of Molecular, Cellular, & Developmental Biology, Yale University, New Haven, CT, USA; Department of Pharmacology, Yale University, New Haven, CT, USA; Department of Chemistry, Yale University, New Haven, CT,…

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • American Cancer Society
  • Howard Hughes Medical Institute

Zitieren

APA

Raina, K., Forbes, C. D., Stronk, R., Rappi, J. P., Eastman, K. J., Zaware, N., Yu, X., Li, H., Bhardwaj, A., Gerritz, S. W., Forgione, M., Hundt, A., King, M. P., Posner, Z. M., Correia, A. D., McGovern, A., Puleo, D. E., Chenard, R., Mousseau, J. J., …, & Crews, C. M. (2024). Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies. Cell Chemical Biology, 31(8), 1490-1502.e42. https://doi.org/10.1016/j.chembiol.2024.07.005

Vancouver

Raina K, Forbes CD, Stronk R, Rappi JP, Eastman KJ, Zaware N, et al. Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies. Cell Chemical Biology. 2024;31(8):1490-1502.e42. doi:10.1016/j.chembiol.2024.07.005

BibTeX
@article{Raina2024,
  author = {Raina, Kanak and Forbes, Chris D and Stronk, Rebecca and Rappi, Jonathan P and Eastman, Kyle J and Zaware, Nilesh and Yu, Xinheng and Li, Hao and Bhardwaj, Amit and Gerritz, Samuel W and Forgione, Mia and Hundt, Abigail and King, Madeline P and Posner, Zoe M and Correia, Allison D and McGovern, Andrew and Puleo, David E and Chenard, Rebekka and Mousseau, James J and Vergara, J Ignacio and Garvin, Ethan and Macaluso, Jennifer and Martin, Michael and Bassoli, Kyle and Jones, Kelli and Garcia, Marco and Howard, Katia and Yaggi, Madeleine and Smith, Levi M and Chen, Jinshan M and Mayfield, Andrew B and De Leon, Cesar A and Hines, John and Kayser-Bricker, Katherine J and Crews, Craig M},
  title = {Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies},
  journal = {Cell Chemical Biology},
  year = {2024},
  volume = {31},
  number = {8},
  pages = {1490--1502.e42},
  doi = {10.1016/j.chembiol.2024.07.005}
}
Kostenlos starten →